Sacituzumab govitecan Archives - Medical Conferences

OS benefit of sacituzumab govitecan in pre-treated HR-positive/HER2-negative metastatic breast cancer

Presented By

Prof. Hope Rugo, Helen Diller Family Comprehensive Cancer Centre, CA, USA

Trial

Phase 3, TROPiCS-02

Conference

ESMO 2022

Type

Peer-reviewed article

16 November 2022 17:43

Sacituzumab govitecan meets primary endpoint

Presented By

Prof. Hope Rugo, University of California San Francisco, CA, USA

Trial

Phase 3, TROPiCS-02

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 12:11

Sacituzumab govitecan effective in platinum-refractory metastatic urothelial cancer

Presented By

Dr Petros Grivas, University of Washington, WA, USA

Trial

Phase 2, TROPHY-U-01

Conference

ASCO GU 2022

Type

Peer-reviewed article

8 April 2022 11:16

Second-line sacituzumab govitecan improves survival in metastatic TNBC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:14

Second- and third-line treatment options in mUC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:41

Understanding MIBC biology for novel treatment options

Presented By

Prof. Yohann Loriot, Université Paris-Saclay, France

Trial

BLC2001; THOR; EV-301; EV-302; TROPHY-U-01; RANGE

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 12:36

Enfortumab vedotin highly active in previously treated advanced urothelial carcinoma

Presented By

Dr Daniel P. Petrylak, Yale School of Medicine, USA

Trial

EV-201, EV-301

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 13:42